CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

Chimeric antigen receptor T cells (CAR T cells) are engineered cells expressing a chimeric antigen receptor (CAR) against a specific tumor antigen (TA) that allows for the identification and elimination of cancer cells. The remarkable clinical effect seen with CAR T cell therapies against hematologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ya-Jui, Mashouf, Leila A., Lim, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899093/
https://www.ncbi.nlm.nih.gov/pubmed/35265074
http://dx.doi.org/10.3389/fimmu.2022.817296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899093/
https://www.ncbi.nlm.nih.gov/pubmed/35265074
http://dx.doi.org/10.3389/fimmu.2022.817296

Ejemplares similares